Tikun Olam-Cannbit Pharmaceuticals Ltd (TKUN.TA)

ILA 38.4

(12.61%)

EBITDA Summary of Tikun Olam-Cannbit Pharmaceuticals Ltd

  • Tikun Olam-Cannbit Pharmaceuticals Ltd's latest annual EBITDA in 2023 was -32.98 Million ILS , down -1211.69% from previous year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd's latest quarterly EBITDA in 2024 Q2 was -1.76 Million ILS , down 0.0% from previous quarter.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd reported an annual EBITDA of 4.83 Million ILS in 2022, up 122.62% from previous year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd reported an annual EBITDA of -13.04 Million ILS in 2021, up 30.18% from previous year.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd reported a quarterly EBITDA of -1.76 Million ILS for 2024 Q2, down 0.0% from previous quarter.
  • Tikun Olam-Cannbit Pharmaceuticals Ltd reported a quarterly EBITDA of -9.03 Million ILS for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Tikun Olam-Cannbit Pharmaceuticals Ltd (2023 - 2011)

Historical Annual EBITDA of Tikun Olam-Cannbit Pharmaceuticals Ltd (2023 - 2011)

Year EBITDA EBITDA Growth
2023 -32.98 Million ILS -1211.69%
2022 4.83 Million ILS 122.62%
2021 -13.04 Million ILS 30.18%
2020 -19.89 Million ILS -74.18%
2019 -9.94 Million ILS 48.97%
2018 - ILS -4813.24%
2017 - ILS 52.9%
2016 - ILS 68.07%
2015 - ILS 30.53%
2014 -4.04 Million ILS 69.66%
2013 - ILS 33.84%
2012 -20.16 Million ILS -189.95%
2011 22.42 Million ILS 0.0%

Peer EBITDA Comparison of Tikun Olam-Cannbit Pharmaceuticals Ltd

Name EBITDA EBITDA Difference
Cannabotech LTD -14.81 Million ILA -122.687%